Skip to main content
Find a Lawyer

United States Federal Circuit


INVITROGEN CORP. v. BIOCREST MFG., L.P., 02-1207, 02-1260

Because the district court incorrectly construed the claims of a patent involving DNA technology, its summary judgment finding that defendant did not infringe plaintiff's patent is reversed.

Appellate Information

  • Decided 05/07/2003
  • Published 05/07/2003

Judges

  • RADER, Circuit Judge., Before RADER, BRYSON, and DYK, Circuit Judges.

Court

  • United States Federal Circuit

Counsel

  • For Appellant:
  • Francis M. Wilkstrom,Parsons Behle & Latimer, of Salt Lake City, UT, argued for plaintiff-appellant.   With him on the brief were C. Kevin Speirs and Kristine Edde Johnson.   Of counsel on the brief was Alan W. Hammond, Invitrogen Corporation, of Carlsbad, CA.

  • For Appellees:
  • Marc R. Labgold, Ph.D., Patton Boggs LLP, of McLean, VA, argued for defendants-cross appellants.   With him on the brief were Kevin M. Bell and Laura A. Donnelly.   Of counsel on the brief was Richard J. Oparil, Patton Boggs LLP, of Washington, DC.
Copied to clipboard